Imbed Biosciences Gains FDA IDE for Silver-Gallium Wound Matrix Trial
Imbed Biosciences has announced that the U.S. Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE)...
Novavax
Advertisement
Novavax’s Nuvaxovid™ 2025–2026 Formula COVID-19 Vaccine Approved in the U.S.
GAITHERSBURG, Md., August 27, 2025 – The U.S. Food and Drug Administration (FDA) has granted approval for Novavax’s Nuvaxovid™...
Advertisement
